Topic Paragraphs
FDA Provides Clarity to Support Cell and Gene Therapy Development and Quality

FDA Provides Clarity to Support Cell and Gene Therapy Development and Quality

 

Featured Topics

Recalls
Report a Problem
Warning Letters
Consumer Updates
483s
EUAs
510Ks
Guidance Documents
Drug Databases
Import Program

FDA in Action

Transparency Makes Modern Regulatory Science Stronger — FDA’s Transparency Roadmap
FDA Approves First Heart Valve Designed to Grow with Children
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
Supporting and Strengthening Domestic Drug Manufacturing
The FDA at 120: A Long, Distinguished History Protecting Americans
Accelerating and Modernizing Early and Late-Stage Clinical Development
Year 1 Goals in Reducing Animal Testing in Drug Development
Results from Largest-Ever Testing of Infant Formula in the U.S.
FDA PreCheck Pilot Program: Strengthening Domestic Pharmaceutical Manufacturing

Press Announcements

November 02, 2026

FDA Provides Clarity to Support Cell and Gene Therapy Development and Quality

October 30, 2026

FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis

October 22, 2026

FDA Launches New Program to Advance Neuroscience Medical Product Development

Products We Regulate

Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood, and Biologics
Animal and Veterinary
Cosmetics
Tobacco Products
Back to Top